title: [Sentinel lymph node biopsy in the breast carcinoma in clinical practice].
abstract: OBJECTIVE
  In the management of early breast carcinoma, biopsy of sentinel lymph nodes has gradually replaced dissection of Level I and II axillary nodes. The aim of the study is to assess feasability and reliability of the method in our conditions.
  
  
  METHODS
  From June 1998 to June 2007, a total of 458 sentinel node biopsies (SLNB) were performed. Originally, patent blue sentinel node mapping was used. Since 2000, a combination of radiocolloid application and a gamma- probe (detector), as well as the patent blue, has been used. Originally, SLNBs were followed by axillary dissections, however, in 2002, the procedure was waived in cases of negative sentinel nodes findings.
  
  
  RESULTS
  Out of the total of 458 SLNB patients, 382 female patients were included in the study. SLNB, without concomitant axillary dissection, was performed in 170 subjects. In 70 subjects, the sentinel node was positive and they were indicated for axillary dissections. Positive non-sentinel nodes were detected 17 times. In total, 899 sentinel nodes were examined in the study group of 382 biopsies. The mean was 2.35. False negative nodes were recorded in three cases in female patients with SLNB and axillary dissection (4.6%). No local relapses in the axilla were recorded in negative sentinel node findings without subsequent axillary dissections.
  
  
  CONCLUSIONS
  Sentinel node biopsy is a safe alternative to axillary dissection in the surgical management of early breast carcinoma.
authors.affiliation: Chirurgické oddelení Nemocnice Atlas a.s. Zlín, Univerzita Tomáse Bati ve Zlíne. gatekj@nemocniceatlas.cz
authors.forename: J
authors.initials: J
authors.lastname: Gatek
authors.forename: L
authors.initials: L
authors.lastname: Hnátek
authors.forename: B
authors.initials: B
authors.lastname: Dudesek
authors.forename: P
authors.initials: P
authors.lastname: Vázan
authors.forename: J
authors.initials: J
authors.lastname: Bakala
authors.forename: K
authors.initials: K
authors.lastname: Hradská
authors.forename: J
authors.initials: J
authors.lastname: Kotoc
authors.forename: T
authors.initials: T
authors.lastname: Musil
authors.forename: J
authors.initials: J
authors.lastname: Duben
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001365:Axilla; D001943:Breast Neoplasms / Q000473:pathology* / Q000601:surgery; D004396:Coloring Agents; D005188:False Negative Reactions; D005260:Female; D006801:Humans; D008197:Lymph Node Excision; D008198:Lymph Nodes; D008875:Middle Aged; D019275:Radiopharmaceuticals; D012394:Rosaniline Dyes; D021701:Sentinel Lymph Node Biopsy; D013668:Technetium Tc 99m Aggregated Albumin
chemical_list: D004396:Coloring Agents; D019275:Radiopharmaceuticals; D012394:Rosaniline Dyes; D013668:Technetium Tc 99m Aggregated Albumin; C083602:technetium Tc 99m nanocolloid; C008769:sulfan blue